Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma

Mantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin’s lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and r...

Full description

Bibliographic Details
Main Authors: Jared Williams, Shingi Chiruka
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2019/2429098
id doaj-38dabe6e80ae445bb780eeabf6fdd894
record_format Article
spelling doaj-38dabe6e80ae445bb780eeabf6fdd8942020-11-25T00:01:19ZengHindawi LimitedCase Reports in Hematology2090-65602090-65792019-01-01201910.1155/2019/24290982429098Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell LymphomaJared Williams0Shingi Chiruka1Department of Haematology, Dunedin Hospital, 201 Great King Street, Dunedin 9016, New ZealandDepartment of Haematology, Dunedin Hospital, 201 Great King Street, Dunedin 9016, New ZealandMantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin’s lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and rituximab-induced acute thrombocytopenia (RIAT) occurring separately, but there are no reports of these occurring in the same patient. Whilst rare, they are important to be aware of as early detection may prevent fatal outcomes.http://dx.doi.org/10.1155/2019/2429098
collection DOAJ
language English
format Article
sources DOAJ
author Jared Williams
Shingi Chiruka
spellingShingle Jared Williams
Shingi Chiruka
Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
Case Reports in Hematology
author_facet Jared Williams
Shingi Chiruka
author_sort Jared Williams
title Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
title_short Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
title_full Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
title_fullStr Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
title_full_unstemmed Spontaneous Splenic Rupture and Rituximab-Induced Acute Thrombocytopenia in a Patient with High-Risk Mantle Cell Lymphoma
title_sort spontaneous splenic rupture and rituximab-induced acute thrombocytopenia in a patient with high-risk mantle cell lymphoma
publisher Hindawi Limited
series Case Reports in Hematology
issn 2090-6560
2090-6579
publishDate 2019-01-01
description Mantle cell lymphoma is a relatively rare type of mature B-cell non-Hodgkin’s lymphoma with an incidence of approximately 8 cases per million persons per year. In patients with mantle cell lymphoma, there are rare case reports of the potentially life-threatening consequences of splenic rupture and rituximab-induced acute thrombocytopenia (RIAT) occurring separately, but there are no reports of these occurring in the same patient. Whilst rare, they are important to be aware of as early detection may prevent fatal outcomes.
url http://dx.doi.org/10.1155/2019/2429098
work_keys_str_mv AT jaredwilliams spontaneoussplenicruptureandrituximabinducedacutethrombocytopeniainapatientwithhighriskmantlecelllymphoma
AT shingichiruka spontaneoussplenicruptureandrituximabinducedacutethrombocytopeniainapatientwithhighriskmantlecelllymphoma
_version_ 1725442633093873664